Disclosure Of Interests In Other Entities [Text Block]

Transgene - Filing #2810948

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Principes de consolidation
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
17 984 EUR
46 506 EUR
Non-current assets
27 233 EUR
19 930 EUR
Current liabilities
10 042 EUR
12 782 EUR
Non-current liabilities
19 563 EUR
15 813 EUR
Profit (loss)
22 328 EUR
22 328 EUR
- EUR
22 328 EUR
- EUR
- EUR
- EUR
- EUR
- EUR
- EUR
32 804 EUR
- EUR
- EUR
32 804 EUR
32 804 EUR
- EUR
Comprehensive income
22 520 EUR
22 328 EUR
- EUR
22 520 EUR
- EUR
- EUR
- EUR
192,000 EUR
- EUR
- EUR
31 831 EUR
- EUR
973,000 EUR
32 804 EUR
31 831 EUR
- EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
192,000 EUR
973,000 EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint operations [text block]
La
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
15 666 EUR
4 403 EUR
5 911 EUR
Tax expense (income)
- EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.